Introduction {#Sec1}
============

Retroviruses exploit subcellular structures to facilitate infection and evade immune surveillance. One of these is bridging conduits (BC), also referred to as tunneling nanotubes, that serve to tether distant cells (Gerdes et al. [@CR25]; Xu et al. [@CR56]). For mononuclear phagocytes (MP; monocytes, macrophages and dendritic cells) such conduits serve as cytoplasmic extensions that facilitate open-ended bidirectional exchange of cellular organelles and proteins amongst cells (Kadiu and Gendelman [@CR30]). They also affect intercellular communication and can facilitate microbial infections (Chinnery et al. [@CR12]; Onfelt et al. [@CR38]; Xu et al. [@CR56]; Kadiu and Gendelman [@CR30]). The human immunodeficiency virus type one (HIV-1) may exploit such high-speed intercellular conduit communication links to accelerate spread of infection in lymphoid and neural tissues. Persistent viral replication would then ensue even during robust humoral immune responses (Gousset et al. [@CR27]; Sowinski et al. [@CR50]). HIV-1 Env, Gag, and Nef were identified in BC (Eugenin et al. [@CR20], [@CR21]; Sowinski et al. [@CR50]; Xu et al. [@CR56]). However, it remained unclear whether these represent mature HIV-1 surfing on the conduits or viral particulates sequestered into endocytic compartments (Eugenin et al. [@CR20], [@CR21]; Xu et al. [@CR56]). More importantly, whether HIV-1's presence in BC facilitates infection or if the virus also engages in receptor-mediated "surfing" of conduits as seen for herpes simplex and murine leukemia viruses (HSV and MLV) (Dixit et al. [@CR18]; Sherer et al. [@CR48]) is not known. As for the latter, HSV and MLV bind to cell surface receptors then travel to neighboring cells where fusion-dependent entry ensues. Here, lateral movement of the lipid bilayer coupled with internal actin retrograde flow facilitates intercellular viral transfers (Sherer and Mothes [@CR47]). HIV-1 may also be sequestered into endosomes then travel in BC for intercellular spread. Recent evidence supports BC endocytic transport of HIV-1 and other pathogens. This is as follows. *First*, transfer of prions through conduits occurs within lysosomes (Gousset et al. [@CR27]). *Second*, for HIV-1, it exploits endosome-BC trafficking pathways for its own sustenance. Viral assembly and budding occurs in intracellular vacuoles, late endosomes and multivesicular bodies (MVB) (Deneka et al. [@CR16]; Orenstein et al. [@CR39]). Macrophage endocytic compartments, such as late endosomes and MVB harbor infectious virus (Pelchen-Matthews et al. [@CR41]; Sharova et al. [@CR46]). *Third*, macrophage not T cell conduits support open-ended bidirectional exchange of endolysosomal compartments between tethered cells (Sowinski et al. [@CR50]; Onfelt et al. [@CR38]). Although HIV-1-macrophage interactions were extensively investigated, the endocytic entry route for HIV-1 transfer was considered non-productive (Miyauchi et al. [@CR37]; Uchil and Mothes [@CR52]). The ability of macrophages to establish BC in vivo at times of robust antiretroviral immune responses is important as the process could be exploited to accelerate viral spread (Ciborowski and Gendelman [@CR14]; Eilbott et al. [@CR19]; Xu et al. [@CR56]).

In attempts to better understand how HIV-1 may use BC for its spread, we studied the mechanism of intercellular viral transfer. Our prior works investigated trafficking through ER and Golgi networks. This was found necessary for HIV-1 cell-to-cell transfer but the pathways and regulatory processes remained ill defined (Kadiu and Gendelman [@CR30]). Thus to this end, we used proteomic, immunologic and cell imaging assays to now demonstrate that HIV-1 is sequestered into clathrin-coated pits then sorted from early endosomes into non-degrading compartments. This included, but was not limited to, Rab11 recycling endosomes and MVB. Actomyosin networks regulated BC compartment mobility. The process occured 25 times faster than those recorded for "surfing" of retroviruses on filopodia (Sherer et al. [@CR48]). Endosomes carry viral cargoes capable of viral gene expression. These data provide novel mechanisms of HIV-1 spread seen during host immune responses and show pivotal insights into what need be overcome in realizing an effective vaccine for viral elimination.

Methods {#Sec2}
=======

Antibodies (Abs) and reagents {#Sec3}
-----------------------------

Rabbit Ab to myosin II, charged MVB protein 4a (CHMP4a) and goat Ab to Rab11 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Human Ab to Gag (recognizes Gag^Pr55^, p24, p17, matrix), gp120, gp160, reverse transcriptase (RT), protease, integrase and the TZM-bl cell line were obtained through the NIH AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH (Bethesda, MD). Rabbit Abs to a- and β-tubulin and lysosome associated membrane protein 1 (LAMP1), as well as mouse and sheep Abs to HIV-1 gp120 were purchased from Novus Biologicals, LLC (Littleton, CO). Mouse Ab to LAMP1, early endosome antigen (EEA1), HIV-1 p24 and human leukocyte antigen (HLA-DR) and poly-D-lysine/fibronectin-coated LabTek chamber slides were purchased from BD Biosciences (San Diego, CA). Rabbit Abs to EEA1 and clathrin were purchased from Cell Signaling Technologies (Danvers, MA). Rabbit anti-mouse and mouse anti-goat secondary Abs conjugated to 6 nm gold particles were purchased from Electron Microscopy Sciences (Hatfield, PA). The following reagents were purchased from Invitrogen (Carlsbad, CA): beta-galactosidase (ß-gal) staining kit, Click-iT RNA Alexa Fluor 594 Imaging Kit, fluorescence in-situ hybridization (FISH) Tag RNA multicolor kit, rhodamine phalloidin, phalloidin Alexa Fluor 488 and 647, transferrin (Tfn) conjugated to Alexa Fluor 594, anti-rabbit Alexa Fluor 488, 594,647, anti-mouse Alexa Fluor 488, 594, 647, anti-sheep Alexa Fluor 488, anti-human Alexa Fluor 488, 1,1'dioctadecyl-3, 3,3',3'-tetramethylindodicarbocyanine perchlorate (DiD), 3,3'dioctadecyloxacarbocyanine perchlorate (DiO), ProLong Gold anti-fading solution with 4′,6-diamidino-2-phenylindole (DAPI). Dulbecco's Modified Medium (DMEM) high glucose with GlutaMax, Dulbecco's Phosphate Buffer Saline (DPBS), Penicillin/Streptomycin were purchased from Gibco/Invitrogen (Carlsbad, CA). Wortmannin, brefeldin A (BFA), blebbistatin (BBST), cytochalasin D (CD), nocodasole (Noc), dynasore, dithiothreitol (DTT), 3-\[(3-cholamidopropyl)-dimethylammonio\]-1-propane sulfonate (CHAPS), urea, thiourea, bovine serum albumin (BSA), triton-X and protease inhibitor cocktail were purchased from Sigma-Aldrich (Saint Louis, MO). COBAS Amplicor HIV-1 Monitor Test, v 1.5 was purchased from Roche Diagnostics Systems, Inc (Brunchburg, NJ).

HIV-1 infection of human monocyte-derived macrophages (MDM) {#Sec4}
-----------------------------------------------------------

Experiments with human peripheral blood mononuclear cells (PBMC) were performed in full compliance of the National Institutes of Health and the University of Nebraska Medical Center ethical guidelines. Monocytes from HIV-1, HIV-2 and hepatitis seronegative human donors were obtained by leukophoresis, and purified by countercurrent centrifugal elutriation (Gendelman et al. [@CR24]). Experiments were performed utilizing primary human monocytes (*N* = 50 independent cultures). Monocytes were grown in suspension cultures using Teflon flasks. Cells were cultured in DMEM supplemented with 10% heat-inactivated human serum, 100 units of penicillin and 100 μg/ml of streptomycin, and 1,000 U/ml highly purified recombinant macrophage colony stimulating factor (MCSF), a generous gift by Pfizer, Inc., (Cambridge, MA). Cells were maintained at 37°C in a 5% CO~2~ atm for 7 d to permit for differentiation into MDM. At day 7, MDM were exposed to the macrophage-tropic strain HIV-1~ADA~ at a multiplicity of infection (MOI) of 0.5 infectious viral particles/cell for 24 h. Prior to seeding in mixed cultures (infected and uninfected MDM), HIV-1 infection was assessed by flow cytometry analysis of cells stained for HIV-1 p24 FITC (Kadiu et al. [@CR31]).

Virus isolation and labeling techniques {#Sec5}
---------------------------------------

Virus isolation was performed as described (Kadiu et al. [@CR31]). Enriched HIV-1 was labeled with 2 μM DiO or DiD for 20 min in phosphate buffered saline (PBS) at 37°C. Virus was resuspended in PBS and centrifuged twice at 100,000 × g on a 20% sucrose cushion to remove unbound dye. For intercellular tracking of virus, labeled HIV-1 was resuspended in culture medium and added to adherent MDM in mixed culture prior to time-lapse microscopy.

Time-lapse confocal imaging {#Sec6}
---------------------------

MDM grown in suspension were labeled with 2 μM DiD (infected) and DiO (uninfected) for 20 min at 37°C in 5% CO~2~. Unbound dyes were removed by washing three times with DMEM supplemented with 10% heat-inactivated human serum at 37°C. Cells were seeded on 35-mm glass-bottom plates (MatTek Corporation, Ashland, MA) in mixed cultures and subjected to live imaging at 37°C and 5% CO~2~. Images were taken in 5 s time intervals, using a 100× oil immersion objective attached to a Nikon TE2000-U utilizing a Swept Field Confocal microscope (Nikon, Tallahassee, FL). Brightness and contrast of the movies were adjusted to improve visibility of particles associated with BC. Imaging of particle movement in BC (from cell body to cell body) was performed manually using the NSI Elements software (Nikon). Particles with trajectories shorter than 10 frames and moving out of focus during recording were excluded from the tracking analysis.

Fluorescence in-situ hybridization {#Sec7}
----------------------------------

Alexa Fluor 488-labeled linearized Gag-Pol probes (2.2 kb; Hind III-Kpn; Lofstrand Labs Limited, Gaithersburg, MD) were generated using FISH Tag RNA Multicolor Labeling Kit (Invitrogen). Probe labeling and in-situ hybridization were performed per manufacturer's instructions.

HIV-1 endocytic entry and intracellular trafficking {#Sec8}
---------------------------------------------------

Adherent MDM were washed three times and incubated with serum free medium for 30 min. Cells were incubated for 30 min with either 100 μM of dynasore in serum-free medium or left untreated. Cells were washed once with serum-free media, then DiD-labeled HIV-1 together with fresh inhibitors was added to MDM for 3 h at 37°C. Cells were washed three times in PBS, mechanically detached using cell lifters (Thermo-Fisher Scientific, Waltham, MA), fixed in 4% paraformaldehyde (PFA) for 30 min and analyzed for viral uptake by flow cytometry. Data was acquired on a FACSCalibur flow cytometer (BD Biosciences) using CellQuest Software (BD Biosciences). For disruption of endocytic sorting, MDM were plated for 3 h in mixed culture, followed by treatment with 1 mM wortmannin and 0.5 mM BFA for 3 h. Cells were washed three times with PBS and fixed with 4% PFA for 30 min. Immunostaining and confocal analyses followed as described below.

Disruption of HIV-1 transport {#Sec9}
-----------------------------

For disruption of endosome motility, uninfected and HIV-1-infected MDM were labeled with DiO (as described above) and plated in mixed culture for 3 h to allow for contact establishment. Cells were exposed to DiD-labeled virus for 1 h and then treated with 50 μM CD, Noc, or BBST for 10 min. Inhibitors were removed, and BC-dependent cell-to-cell endosome transfer was determined by time-lapse confocal microscopy and particle tracking analyses. A group of inhibitor-treated and untreated unlabeled cells in mixed culture were stained for HIV-1 Env and Gag and myosin II and imaged by confocal microscopy.

Imaging of recycling compartments {#Sec10}
---------------------------------

MDM in mixed culture were seeded onto poly-D-Lysine-coated chamber slides for 3 h devoid of human serum. Cells were incubated with 1 μM Alexa 594-Tfn or DiO-labeled HIV-1 for 1 h. Non-internalized particulates were removed by three sequential washes with PBS. Cells were fixed with 4% PFA and imaged using the 63× oil lens of a LSM 510 confocal microscope (Carl Zeiss MicroImaging, LLC, Thornwood, NY).

Metabolic labeling of RNA and proteins {#Sec11}
--------------------------------------

Metabolic labeling and detection of newly synthesized RNA was performed using Click-It RNA labeling kit per manufacturer's instructions (Invitrogen). Metabolic incorporation of 5-ethynyl uridine (EU) was extended to 24 h. Additional immunostaining and imaging of the MDM was performed as described below.

Immunocytochemistry and confocal microscopy {#Sec12}
-------------------------------------------

For immunofluorescence staining, cells were washed three times with PBS and fixed with 4% PFA at room temperature for 30 min. Cells were treated with blocking/permeabilizing solution (0.1% Triton, 5% BSA in PBS) and quenched with 50 mM NH~4~Cl for 15 min. Cells were washed once with 0.1% Triton in PBS and sequentially incubated with primary and secondary Ab at room temperature. For MDM stained with multiple antibodies, non-specific cross binding of secondary Abs was tested prior to immunostaining. Use of secondary antibodies originating or recognizing the same hosts was avoided. Slides were covered in ProLong Gold anti-fading reagent with DAPI and imaged using a 63X oil lens in a LSM 510 confocal microscope (Zeiss).

Enrichment of macrophage protrusions and proteomic characterization {#Sec13}
-------------------------------------------------------------------

Enrichment of the macrophage protrusions was performed as described with some modifications (Beckner et al. [@CR3]). Prior to BC collection, cells were maintained in Teflon flasks and media was changed every 2 d to maintain the infected MDM cultures metabolically stable. Cells were then seeded on a 9 mm thick, 3-μm pore polycarbonate filter of a Boyden chemotaxis apparatus (NeuroProbe, Gaithersburg, MD) and maintained at 37°C in a 5% CO~2~ tissue culture incubator for 3 h. Prior to harvesting of BC, each filter was first immersed in 100% methanol for 15 s then placed with migrated cell materials (attached to the undersurface of the filter) on a glass slide. Each filter was firmly pressed against a glass slide to promote adherence of migrated cellular processes. Cell bodies were wiped from the filter top, and the filter was then gently peeled off the slide with forceps. The processes were solubilized in lysis buffer pH 8.5 \[30 mM Tris HCl, 7M urea, 2M thiourea, 4% (*w*/*v*) CHAPS, 20 mM DTT and 1X protease inhibitor cocktail by pipeting. The remainder of the lysate was allowed to crystallize on slides and harvested using razor blades. One-dimensional gel electrophoresis, mass spectrometry and database searches were performed as described (Kadiu et al. [@CR32]).

Scanning and transmission electron microscopy {#Sec14}
---------------------------------------------

MDM were seeded in mixed culture on Thermanox coverslips (Thermo-Fisher Scientific) and allowed to establish BC for 24 h. Cells were then washed with PBS and fixed in 2% glutaraldehyde and 2% PFA in 0.1M Sorensen's phosphate buffer (SPB). Post-fixation cells were exposed to 1% osmium tetraoxide for 30 min and dehydrated at 50%, 70%, 90%, 95%, and 100% ethanol for 10 min. Samples for transmission electron microscopy (TEM) were embedded in Araldite. Coverslips were removed and areas of the cell culture were selected for ultrathin (60 nm thick) sectioning. Cells were sectioned on the plane of the colony and in cross sections. Sections were stained with uranyl acetate and lead citrate and observed in a Tecnai G2 Spirit TEM (FEI Company, Hillsboro, OR). Samples for scanning electron microscopy (SEM) were critical point dried, mounted on specimen stubs and sputter coated with 40 nm of gold/palladium. Samples were observed with FEI Quanta 200 SEM (FEI Company) operated at 25 kV. For immunogold labeling, MDM in mixed infected and uninfected cultures were fixed with 2% glutaraldehyde and 2% PFA in 0.1M SPB for 24 h. Cells were washed in PBS and permeabilized with 0.5% Triton-X and 3% BSA in PBS for 24 h then incubated with primary Ab for 4 h at ambient temperature. Between incubation with gold conjugated Ab (6 nm) for 2 h, MDM were washed three times in 0.5% Triton-X and 3% BSA. Cells were then post-fixed with 2% glutaraldehyde and 2% PFA in 0.1M SPB and processed for TEM as described above.

Enrichment of endocytic compartments {#Sec15}
------------------------------------

Immune isolation of endocytic compartments was performed as previously described, with some modifications (Basyuk et al. [@CR2]). MDM (400 × 10^6^ cells) were seeded in mixed cultures (uninfected and infected MDM at equal ratios) and allowed to establish BC for 24 h (\>90% of cell population connected by BC). Cells were scraped in homogenization buffer (10 mM HEPES-KOH, pH 7.2, 250 mM sucrose, 1 mM EDTA, and 1 mM Mg(OAc)~2~) and disrupted by 15 strokes in a dounce homogenizer. Nuclei and unbroken cells were removed by centrifugation at 800 × g for 15 min at 4°C. Supernatant was layered on a 20% sucrose cushion and centrifuged at 100,000 × g for 1 h. The pellet was resuspended in 40% sucrose, 10 mM imidazole solution pH 7.4 followed by layering on 60%, 35%, 20% and 10% sucrose gradient and centrifugation at 100,000 × g at 4°C for 1 h. The interfaces between 10% and 20% and 40% and 35% sucrose bands containing enriched endocytic compartments were collected and washed in PBS using ultracentrifugation at 100,000 × g. Pellets were then incubated with protein A/G paramagnetic beads (20 μl of slurry; Millipore) previously conjugated to endosome Ab (10 μg of Ab) for 12 h at 4°C. Endocytic compartments were washed and collected on a magnetic separator (Invitrogen). For TEM imaging endocytic compartments were fixed in 2% glutaraldehyde and 2% PFA in 0.1M SPB for 3 h and then isolated by magnetic separation. The bead-endosome pellet was then covered in agar and processed for TEM as described above.

Reporter cell line {#Sec16}
------------------

TZM-bl cells were cultured in DMEM supplemented with 10% fetal bovine serum, 100 units of penicillin and 100 μg/ml of streptomycin. Cells were allowed to reach 70% confluence, then detached by 25 mM trypsin/EDTA for 5 min at 37°C. Detached cells were cultured and allowed to recover in 4 well poly-D-lysine LabTech chamber slides for 2 d or until they reached 40% confluence. Protein A/G paramagnetic beads bound to isotype control Abs or endocytic compartments (20 μl of slurry/500 μl of medium/well), and HIV-1 Tat protein (2 μM) were reconstituted in supplemented DMEM and added to cells. Replicate wells were pre-treated with 100 μM Efavirenz (EFZ) for 24 h prior to exposure to endocytic compartments. Chamber slides were placed on a plate magnet (Oz Biosciences/Boca Scientific, Boca Raton, FL) for 24 h at 37°C in 5% CO~2~ after addition of endocytic compartment-bead conjugates. The magnet was removed and cells were washed three times with PBS and maintained in culture medium for additional 48 h prior to β-gal detection (per manufacturer's instructions). Bright field images were acquired using a Nikon Eclipse TE300 microscope (Nikon).

Quantitation of endosome viral load {#Sec17}
-----------------------------------

RNA viral load for EEA1^+^, Rab11^+^, CHMP4^+^ and LAMP1^+^ immune-isolated compartments was measured using COBAS Amplicor HIV-1 Monitor Test, v 1.5 and COBAS AmpliPrep Instrument for automated specimen processing (Roche Diagnostics) per manufacturer's instructions.

Colocalization tests and statistical analyses {#Sec18}
---------------------------------------------

Quantitation of immunostaining and Pearson's colocalization coefficients was performed with ImageJ software, utilizing JACoP plugins (<http://rsb.info.nih.gov/ij/plugins/track/jacop.html>) (Bolte and Cordelieres [@CR5]). Comparison was performed on 7--10 sets of images (whole cells) acquired with the same optical settings. To improve visibility of subcellular compartments in the BC, brightness and contrast settings were changed for the entire image in select images using Adobe Photoshop. Graphs and statistical analyses were generated using Excel and GraphPad Prism. Two-tailed Student's *t*-tests were used for all data and the error bars are shown as ± S.E.M., unless noted otherwise. Results were considered significant at *P* \< 0.05.

Results {#Sec19}
=======

BC speeds communication between MDM {#Sec20}
-----------------------------------

We first assessed the abilities of BC to affect exchange between infected and uninfected MDM. This was done first by measures of the dynamics of contact formation between cells. Cells were propagated in suspension Teflon cultures in complete media containing MCSF. Half of the cells were infected with HIV-1~ADA~ at a MOI of 0.5 infectious viral particles/cell and the second half were uninfected. After 7--10 days, greater than 96% of cells within the infected cultures were HIV-1p24 positive (as assayed by flow cytometry, Fig. [1a](#Fig1){ref-type="fig"}). At that time, the infected and uninfected MDM were mixed at equal ratios. These were defined as mixed cultures. BC formation between infected and uninfected cells was confirmed by confocal imaging of mixed cell cultures immunostained for HIV-1 Env glycoproteins (gp120/gp160) and microtubules (alpha/beta tubulin). Images showed cellular protrusions connecting HIV-1 Env^+^ (red) to Env− (green) uninfected MDM (Fig. [1b](#Fig1){ref-type="fig"}, arrows). BC frequency was measured in mixed cell cultures at 30, 60 and 180 min and was time dependent. Number of cells connected by BC increased significantly at 60 (*P* \< 0.0001) and 180 min (*P* = 0.0077; Fig. [1c](#Fig1){ref-type="fig"}). At 180 min BC displayed tubular morphologies (Fig. [1d](#Fig1){ref-type="fig"}, arrows). Unlike T cell conduits that form as two touching cells which move away from each other (Sowinski et al. [@CR50]), macrophage BC extend from one cell to their target and display three-dimensional flagellum-like movements (Movie [S1](#MOESM10){ref-type="media"}). Their length and diameter average 110 ± 57 μm and 7 ± 4 μm (mean ± S.D., *n* = 238 cells; Fig. [1e,f](#Fig1){ref-type="fig"}). BC were distinct from non-tethered protrusions used by macrophages for cell migration, which include bulbous lamellipodia (Fig. S[1](#Fig8){ref-type="supplementary-material"}A) or thin and short filopodia (Movie [S2](#MOESM11){ref-type="media"}) (Lundquist [@CR33]; Vonna et al. [@CR53]). To best visualize BC-mediated communications, uninfected and infected MDM were labeled with DiO (green) and DiD (red) lipophilic dyes, respectively. Such dyes are sequestered into endocytic compartments and can be used to measure long-term endocytic trafficking (Rustom et al. [@CR45]; Sowinski et al. [@CR50]). To accomplish this task, DiO- and DiD-labeled cells were removed from suspensions and plated in mixed culture. Time-lapse images at 30 min during adherence demonstrated that virus-infected MDM readily generated BC. Particle tracking showed that endosome transfer through BC occurred immediately after cell contact at 1.0 ± 0.7 μm·s^−1^ (mean ± S.D., *n* = 80 particles; Fig. [1g,h](#Fig1){ref-type="fig"}). MDM in "pure" infected and in mixed infected and uninfected cultures displayed increased intra- and intercellular endocytic traffic when compared to uninfected cells alone (Movies [S3](#MOESM12){ref-type="media"}--[S5](#MOESM14){ref-type="media"}). Since both BC and secreted vesicles contribute to intercellular communication, lipid transfer activity was measured in the presence (adherent cultures) and absence (suspension cultures) of BC (Simons and Raposo [@CR49]). Overall lipid transfer peaked at 180 min, with 42% of the cells displaying dual dye labeling. Of these only 19% acquired dual fluorescence through BC. Together these data demonstrate that macrophage BC connect infected to uninfected cells. Fig. 1BC sustain communication between uninfected and infected MDM. **a** Assessment by flow cytometry of HIV-1 infection in single culture MDM. **b** Formation of BC between infected and uninfected MDM labeled for HIV-1 envelope (*red*) and microtubules (*green*). Observe presence of HIV-1 Env along the conduit (*scale bars*, 10 μm, inset, 5 μm). **c** Frequency of BC formation in MDM uninfected, infected and mixed cultures (equal ratios of uninfected and infected MDM) at 30, 60 and 180 min in adherence (*n* = 450 cells/group, *error bars* ± S.E.M). Data are representative of five independent experiments. **d** Bright field images of conduits connecting MDM in mixed culture. *Arrows* indicate tethering sites (*scale bar*, 10 μm). **e, f** Frequency of conduit length and diameter observed in MDM mixed populations (*n* = 238 cells). **g** Time-lapse confocal images showing contact establishment and lipid transfer through BC from infected (DiD-labeled, *red*) to uninfected (DiO-labeled, *green*) MDM. **h** Velocity of lipid transfer through the BC. *Graph* reflects average velocity values recorded at each time point for 80 particles tracked along the BC (*error bars* ± S.E.M.). **i** Intercellular transfer activity in mixed MDM in presence (adherent cultures) and absence (suspension cultures) of conduits. Ratios of cells affected by this process over time (*yellow*, *upper right quadrants*) compared to the overall red (DiD-labeled infected MDM, *upper left quadrants*) and green populations (DiO-labeled, uninfected MDM, *lower right quadrants*) are shown in *bold*

HIV-1 constituents in BC {#Sec21}
------------------------

We next asked whether HIV-1 constituents are present in the conduits. This is a seemingly important question for viral spread and likely present as BC facilitate transfer of cellular material between infected and uninfected MDM. Punctate distribution of HIV-1 RNAs in BC and cell body was visualized by fluorescence in situ hybridization. This was visualized by HIV-1 Gag-Pol probes labeled with Alexa Fluor 488 (Fig. [2a](#Fig2){ref-type="fig"}, inset boxes 1 and 2). Whole cell and viral RNA metabolically labeledwith 5-ethynyl uridine-Alexa Fluor 594 was co-distributed with Env, Gag and RT within large compartments in BC (Table S[1](#MOESM1){ref-type="media"}). Env, capsid (Gag including Gag^Pr55^, p24, p17, matrix), RT, integrase, protease, Tat and Vif were readily identified in BC (Fig. [2b--h](#Fig2){ref-type="fig"}). Interestingly, such BC-associated viral constituents appeared as large particulates (0.5--2.5 μm in diameter) and were confined to the BC cortical actin (phalloidin-Alexa Fluor488; Fig. [2e--h](#Fig2){ref-type="fig"}; Table S[1](#MOESM1){ref-type="media"}). These data demonstrate that HIV-1 constituents (HIV-1 proteins and viral RNA) are present in macrophage BC. Fig. 2HIV-1 constituents are identified in the BC. **a** Detection by fluorescence in-situ hybridization of viral RNA using Alexa Fluor488-labeled HIV-1 Gag-Pol probes (*green*). Confocal and differential interference contrast (DIC) images show presence of HIV-1 RNA in the cell body and conduits (insets 1 and 2). **b--d** HIV-1 Env (*green*), Gag (Gag^Pr55^, p24, p17, matrix; *green*), RT and RNA Alexa Fluor594 (*red*, metabolically-labeled with 5-ethynyl uridine) are readily visible in the conduits. (Refer to Table [S1](#MOESM1){ref-type="media"} for newly synthesized RNA and viral protein co-localization coefficients). **e--h** HIV-1 protease (*red*), integrase (*red*), Tat and Vif (*red*) are present in the BC. Staining for cortical actin (phalloidin-Alexa Fluor 488) and nuclei (DAPI, *blue*) was performed to distinguish MDM connected by the conduits from polarized single cells (*scale bar*, 10 μm; inset, 5 μm)

HIV-1 is sequestered into endosomes {#Sec22}
-----------------------------------

The presence of HIV-1 Env-CD4 complexes in the conduits would suggest that virus exploits receptor-dependent "surfing" on BC to reach neighboring target cells (Martin and Sattentau [@CR35]; Sowinski et al. [@CR50]). We then asked whether such a manner of viral transport would require mature progeny HIV-1 on the exterior of BC. Thus, the presence of CD4-Env complexes associated with macrophage conduits was assessed. Confocal imaging of MDM identified large particulates (0.5--2 μm) of CD4^+^ and Env^+^ in the conduits (Fig. S[2](#Fig9){ref-type="supplementary-material"}A, inset boxes 1 and 2). SEM revealed BC tubular morphologies and its plasma membrane sheathing of vesicle-like compartments (Fig. [3a,b](#Fig3){ref-type="fig"}). TEM revealed heterogeneous populations of BC containing endocytic vesicles varying in coating, size and electron densities (Fig. [3c](#Fig3){ref-type="fig"}, inset 1 and arrows). Plasma membrane microvesicles were on the surface of the BC (Fig. S[2](#Fig9){ref-type="supplementary-material"}B). Fifty-five cross-sections (60 nm thick) of MDM in mixed cultures were generated (*n* = 5 independent experiments). Mature virions were identified in the extracellular space of ten sections (Fig. S[2](#Fig9){ref-type="supplementary-material"}C, inset 1, red arrow), however none were observed anchored to the BC plasma membrane (*n* = 70 conduits imaged). Disruption of BC using microflament and microtubule inhibitors CD and Noc, respectively suppressed productive infection at similar levels to the protease inhibitor Atazanavir (ATV). Treatment with neutralizing antibodies did not alter levels of HIV-1 infection or its presence in the BC (Fig. S[2](#Fig9){ref-type="supplementary-material"}D). On the contrary early endosomes containing anti-Env Ab and CD4 were readily identified in the BC (Fig. S[2](#Fig9){ref-type="supplementary-material"}E, F). Interestingly, inhibition of clathrin-dependent endocytosis blocked uptake of fluorescently labeled HIV-1 (Fig. S[2](#Fig9){ref-type="supplementary-material"}G). HIV-1 and CD4 were present within large clathrin^+^ compartments in the cell body and BC (Fig. S[2](#Fig9){ref-type="supplementary-material"}H, arrows). TEM imaging of immunogold-labeled mixed MDM cultures showed Gag (Gag^Pr55^, p24, p17, matrix) punctate staining of endocytic vesicles (arrows indicate gold-laden compartments). In some instances, capsid-like morphologies were observed within these same structures (Fig. [3d](#Fig3){ref-type="fig"}, blue arrow). These data, taken together, suggested that BC-associated HIV-1 was sequestered into endocytic compartments. Fig. 3Ultrastructural and biochemical characterization of BC. **a, b** SEM image of macrophage conduit reveals vesicle-like structures sheathed by plasma membrane. **c** TEM image of a sectioned conduit shows coated and uncoated vesicles of various sizes and electron densities, and large lipid droplets (inset 1 and 2, *arrows*). **d** TEM image of BC cross-sections generated from polarized MDM in mixed culture. Cells were immunostained for HIV-1 Gag. Secondary Ab conjugated to 6 nm gold particles was used for detection. *Arrows* (*red*) indicate endocytic compartments laden with gold particles. Rare capsid-like dense structures were observed in endocytic vesicles (*blue arrow*). **e** SEM image of infected macrophages seeded in the upper chamber of a Boyden chemotaxis apparatus, extending their processes through a polycarbonate porous membrane towards the lower chamber (*arrows*). **f** Classification by function of the proteins identified with two or more significant (*P* \< 0.05) and unique peptides in the BC proteome (pooled sample from five independent experiments). Refer also to Table [S2](#MOESM2){ref-type="media"} for a list of proteins identified in the conduits

Characterization of the BC endocytic transport machinery {#Sec23}
--------------------------------------------------------

We next sought to identify the intercellular transport compartments for HIV-1. To this end, we characterized the proteome of the macrophage conduits. To mimic formation of BC in mixed cultures, HIV-1-infected MDM were seeded on a filter membrane separating them from the lower chamber of a Boyden chemotaxis apparatus containing uninfected MDM-conditioned medium (Fig. S[3](#Fig10){ref-type="supplementary-material"}A--B). Figure [3](#Fig3){ref-type="fig"}e shows infected MDM extending their processes through filter pores unto the lower chamber (arrows). Protrusions were mechanically detached from the cell bodies and visualized by bright field and confocal microscopy (Fig. S[3](#Fig10){ref-type="supplementary-material"}C, D). Proteomic characterization of enriched conduits identified early, late and recycling endosomes, MVB, lysosomes and actin-binding proteins. Regulators of endocytic sorting, including Rab GTP-ases (Rab1, 2, 5, 7a, 11a) and late endosome-lysosomal markers (annexin II and IV, MHCI, MHCII, as well as ubiquitin and cathepsin isoforms) (Jouve et al. [@CR29]; Zerial and McBride [@CR57]) accounted for 13% of the conduit proteome (Fig. [3f](#Fig3){ref-type="fig"}; Table S[2](#MOESM2){ref-type="media"}). Proteins driving endosome movement and regulators of actin stress fibers such as myosin motor proteins IC, II, light chain (LC) 6 and heavy chain (HC) 9, together with other actin-binding proteins represented 14% of the overall proteome, while HIV-1 proteins accounted for 4%. These findings indicated that active endocytic transport of HIV-1 occurred in the macrophage conduits.

Endosomes, HIV-1 and BC {#Sec24}
-----------------------

Next, we examined HIV-1 distribution within individual endocytic compartments of the BC. MDM were exposed to DiD- or DiO-labeled HIV-1 for 3 h. Equivalent numbers of uninfected MDM were added and allowed to establish BC between adherent cells. Cells were then fixed and immunostained for endosome markers that included EEA1 for early endosomes, HLA-DR for MVB and LAMP1 for late endosomes/lysosomes. For tracking of HIV-1 with recycling endosomes, MDM were exposed to both fluorescently labeled HIV-1 and Tfn-Alexa Fluor 568. Fluorescently labeled HIV-1 was observed within multiple endocytic compartments (Figure S[4](#Fig11){ref-type="supplementary-material"}A--C). However, Pearson's colocalization test indicated preferential association of HIV-1 with early (68 ± 2%), recycling endosomes (57 ± 4.1%) and MVB (82 ± 0.1%; mean ± S.E.M; Fig. S[4](#Fig11){ref-type="supplementary-material"}A--C). Since, HIV-1 uncoating can occur in early endosomes, tracking of fluorescently labeled HIV-1 (envelope-labeled with lipophilic dyes) into endocytic compartments may not reflect the fate of all viral constituents (Miyauchi et al. [@CR37]). Therefore, we investigated endocytic sorting of each viral constituent (Env, Gag and RNA) separately. Similar to fluorescently labeled HIV-1, Env, Gag and RNA were readily identified within early endosomes, MVB, recycling endosomes (Rab11a) and lysosomes in the BC (Fig. [4a--k](#Fig4){ref-type="fig"}). CHMP4a was used as an MVB marker instead of HLA-DR, as HLA-DR is abundantly present in both the HIV-1 envelope and MVB (Ott et al. [@CR40]). CHMP4a is a member of the endosomal-sorting complex required for transport (ESCRTIII) family, which together with tumor susceptibility gene 101 (Tsg101) regulates early endosome-to-MVB sorting and HIV-1 budding within MVB (Babst et al. [@CR1]; Deneka et al. [@CR16]; Welsch et al. [@CR55]). Immunostaining for Rab11a, a regulator of fast (Tfn receptor) and slow endocytic recycling, was performed to expand detection of recycling endosome populations (Trischler et al. [@CR51]). Metabolic labeling of RNA (cellular and viral) was chosen over FISH (gag-pol probes) since tissue degradation by proteinase K during FISH interferes with additional immunostaining for endocytic markers. Env, Gag and RNA were present at varying levels in BC endosomes. However, significant (*P* \< 0.05) levels of Env were seen within early and recycling endosomes (Fig. [4l](#Fig4){ref-type="fig"}). Gag and RNA preferentially (*P* \< 0.05) colocalized with MVB and Rab11 endosomes (Fig. [4m,n](#Fig4){ref-type="fig"}). Fig. 4Distribution of HIV-1 constituents with BC endocytic compartments. **a--k** Confocal images of MDM in mixed culture showing distribution of HIV-1 Env (*red*, panels **a, c, d** and *blue*, **b**), Gag (*green*, **b** and *red*, **e--g**), metabolically labeled RNA (*red*) with early endosomes (*green*), MVB (*green*), recycling endosomes (*green*), and lysosomes (*green*) identified in the conduits (*scale bars*, 10 μm; insets, 5 μm). **l--n**, Pearson's colocalization tests of HIV-1 Env, Gag and RNA distribution with BC endocytic compartments. Pearson's colocalization coefficients were converted to percent overlap between fluorophores (*error bars* ± S.E.M., *n* = 80 cells)

Intra- and intercellular trafficking of HIV-1 constituents in MVB-Rab11 recycling endosomes {#Sec25}
-------------------------------------------------------------------------------------------

Having identified Env, Gag and RNA in several endosome populations and their preferential distribution with recycling endosomes, we next queried whether HIV-1 sorting routes converged with the recycling pathway. Endosomes and lysosomes may undergo partial fusion with late and recycling endosomes to form temporary recycling hybrid compartments targeted for the plasma membrane (Blott and Griffiths [@CR4]; Bright et al. [@CR7]; Luzio et al. [@CR34]). This process would explain the overlap in endocytic distribution of HIV-1. Indeed, partial colocalization of EEA1 (54 ± 2%), LAMP1 (34 ± 1%) and CHMP4a (34 ± 2%; mean ± S.E.M., *n* = 80 cells/group) was observed with Rab11^+^ compartments. In addition, endosomes carrying both early endosome and MVB markers were also identified (Figure S[5](#Fig12){ref-type="supplementary-material"}A--C). Disruption of MVB biogenesis using wortmannin (Gruenberg and Stenmark [@CR28]) and endocytic recycling with BFA (Wang et al. [@CR54]) caused aggregation of Gag in large perinuclear vacuoles and excluded Gag from the BC (Figure S[5](#Fig12){ref-type="supplementary-material"}D, E). Collectively, these findings demonstrate that dissemination of HIV-1 constituents through the conduits occurs within endosomes and is regulated primarily by the MVB-Rab11a recycling route.

Endocytic compartments carry infectious virus {#Sec26}
---------------------------------------------

Although intercellular transmission of retroviruses by cellular extensions has been estimated at 100--1,000 times faster than cell-free virus, it is unknown whether this mode of viral dissemination results in infection (Martin and Sattentau [@CR35]; Sowinski et al. [@CR50]). Previous studies have shown that HIV-1 sequestered within macrophage endocytic compartments is infectious (Pelchen-Matthews et al. [@CR41]; Sharova et al. [@CR46]). Therefore, we tested whether this was the case for endocytic compartments in polarized macrophages. MDM (\>90% of cell tethered by BC) were mechanically disrupted and the endosome fraction was collected by sucrose gradient. Protein A/G magnetic beads conjugated with Ab to EEA1, CHMP4a, Rab11a Ab, and LAMP1 were incubated with the endosome fraction and isolated by magnetic separation (Fig. [5a](#Fig5){ref-type="fig"}). Protein A/G paramagnetic beads conjugated to pooled isotype control antibodies were used to preclude non-specific binding of other subcellular membranes. Enrichment of endocytic compartments was confirmed by TEM. Figure [5](#Fig5){ref-type="fig"}b shows high electron density endosomes bound to a magnetic bead (inset 1, arrows). Fig. 5Endocytic compartments carry infectious viral cargo. **a** Illustration of immunoisolation of endocytic compartments from polarized MDM in mixed culture and their magnet-induced entry in TZM-bl reporter cell line. **b** TEM of enriched endocytic compartments bound to paramagnetic beads. *Arrows* indicate high-density endosomes. **c** HIV-1 viral load (RNA copies) in early endosomes, lysosomes, MVB and recycling endosomes and isotype control Abs. **d, e** Representative bright field images of uninfected TZM-bl, cells exposed to HIV-1 Tat, cell-free HIV-1, and immune-isolated endocytic compartments expressing different levels of ß-gal (*blue*) at 72 h post-exposure. *Arrows* indicate paramagnetic beads (*brown*) within TZM-bl. **f** Representative images of TZM-bl showing susceptibility of cell-free and endocytic HIV-1 infection to antiretroviral treatment. **g** Quantiation of overall endosome infectivity and susceptibility to antiretroviral therapy (efavirenz) in TZM-bl (*scale bars* 100 μm; *error bars*, ± S.E.M., *n* = 400 cells/group, *N* = 2 independent experiments)

Next, we determined the viral load (HIV-1 RNA copies) in each isolated endosome population. COBAS Amplicor analysis showed endosomes carried high viral loads (∼10^4^ HIV-1 RNA copies/μg of Ab; Fig. [5c](#Fig5){ref-type="fig"}). Numbers of HIV-1 RNA copies were distinct for each endosome population (Fig. [5c](#Fig5){ref-type="fig"}). Rab11 endosomes displayed the highest viral load (3.2 × 10^4^ RNA copies/μg of Ab) further supporting the role of the recycling pathway in viral trafficking. HIV-1 viral load for the isotype control pool was at background level, thus excluding non-specific binding to other virus-containing membranes. To establish infectivity of endocytic viral cargo, we used a TZM-bl reporter cell line, which contains an integrated copy of the ß-gal gene under control of the HIV-1 promoter (Platt et al. [@CR42]). In MDM connected by BC, we and others have observed a seamless flow of endosomes between infected (DiO-labeled) and uninfected cells (DiD-labeled cells; Fig. S[6](#Fig13){ref-type="supplementary-material"}A, B) (Onfelt et al. [@CR38]). Upon reaching the target cells, endosomes either preserve their characteristics or fuse with native endosomes (encircled yellow). To test infectivity of endocytic cargoes, we mimicked direct access of endosomes to the intracellular milieu of the target cells. To accomplish this, we considered the following limitations: *First*, the TZM-bl reporter cell line has limited phagocytic characteristics and the immune isolated endosomes do not carry surface molecules (i.e., Fc receptors) necessary for internalization. Therefore, this excluded the possibility of receptor-mediated endocytosis as a mode of introducing the isolated compartments to the intracellular environment of TZM-bl. *Second*, isolated endosomes remain attached to the bulky magnetic beads (10--15 μm in diameter) that constituted a large cell entry barrier. Therefore, to gain access into the cytoplasm of the target cells (as it would occur via open-ended BC), endosome-bead complexes were forced into the TZM-bl by exposure to strong magnetic fields (Fig. [5a](#Fig5){ref-type="fig"}). Integration and expression of viral genome were confirmed by ß-gal detection (blue) at 72 h post-exposure (Fig. [5d,e](#Fig5){ref-type="fig"}). Cells exposed to Rab11a and CHMP4a endosomes induced similar levels of ß-gal as those observed with cell-free HIV-1 (*P* \> 0.05). The infectivity of early endosomes and lysosomes was measured at significantly lower levels than cell-free HIV-1 (*P* \< 0.001, Fig. [5g](#Fig5){ref-type="fig"}). Since, HIV-1 Tat^+^ compartments were identified in the BC, we questioned whether the expression of ß-gal could be induced by Tat alone. TZM-bl were exposed to 2 μM recombinant Tat for 24 h and then stained for ß-gal. Tat treatment altered the cellular morphology of TZM-bl compared to untreated uninfected cells; however similar to control exposure, Tat alone did not induce ß-gal expression (Fig. [5d](#Fig5){ref-type="fig"}). Pre-treatment of TZM-bl with EFZ (a non-nucleoside reverse transcriptase inhibitor) prior to endosome exposure significantly (*P* \< 0.0001) reduced ß-gal expression (Fig. [5f,g](#Fig5){ref-type="fig"}). These findings indicate infectious viral cargoes are preserved within endosomes and are capable of inducing *bona fide* infections.

HIV-1 is transported through the BC in non-degrading endocytic compartments {#Sec27}
---------------------------------------------------------------------------

Next, we examined the role of endosome transport in viral propagation. MDM labeled with DiD were exposed to fluorescently labeled HIV-1 and allowed to establish viral transfer through the conduits to the uninfected cells (Movie [S6](#MOESM15){ref-type="media"}). Alternatively, cells exposed to DiO-HIV-1 were treated with CD, Noc and BBST. CD and Noc were tested for inhibition of endocytic transport due to involvement of actin tails and microtubules in the propulsion of endosomes (DePina and Langford [@CR17]).

BBST, a non-muscle myosin II inhibitor, was used to test myosin II-dependent transport of viral constituents. Among the myosin isoforms identified in the BC proteome, myosin II was further investigated due to its high co-distribution with viral proteins (Fig. [6a](#Fig6){ref-type="fig"}) and endocytic compartments (Fig. S[7](#Fig14){ref-type="supplementary-material"}A--D). Cells exposed to HIV-1 alone and to CD, Noc or BBST were subjected to viral particle tracking analysis by still and time-lapse confocal imaging. Treatment with inhibitors induced aggregation of HIV-1 Env/Gag in the perinuclear region in CD- and Noc-treated MDM and large vacuoles in BBST-treated cells (Fig. [6b](#Fig6){ref-type="fig"}). In untreated cells the velocity of viral transfer averaged at 1.1 ± 0.1 μm·s^1^ (mean ± S.E.M., *n* = 70 particles). Exposure to CD, Noc, or BBST significantly suppressed endosome movement at each time point, including average velocity (*P* \< 0.0001), path length (*P* \< 0.0001) and displacement (*P* \< 0.0001, *n* = 70 particles/group) compared to untreated cells (Fig. [6c--e](#Fig6){ref-type="fig"}). Together these findings demonstrate that cell-to-cell spread of HIV-1 through BC is dependent upon the integrity of endocytic and actin-myosin networks. Fig. 6Dependence of viral transfer on integrity of endocytic transport. **a, b** Distribution of myosin II with HIV-1 Env and Gag, in MDM untreated or exposed to CD, Noc or BBST post-formation of BC (*scale bar*, 10 μm). **c--e** Disruption of endosome/viral motility by CD, Noc or BBST. Progressive average movement was determined using the mean velocity (μm•s^−1^), path length (μm), and displacement from the origin for all analyzed particles (*error bars*, ± S.E.M., *n* = 70 particles/group, *N* = 3 independent experiments) at each time point for 120 s

Discussion {#Sec28}
==========

We demonstrated that unlike other retroviruses that "surf" cellular protrusions, HIV-1 exploits endocytic traffic through bridging conduits for its intercellular spread. In previous studies, viral endocytic entry was shown to effect the viral life cycle (Martin and Sattentau [@CR35]; Uchil and Mothes [@CR52]). HIV-1 enters the cell by clathrin-mediated endocytosis and uncoating, occurs in endocytic compartments (Miyauchi et al. [@CR37]). Indeed, genomic screens for host proteins required for infection demonstrate a dependency of HIV-1 replication on the integrity of the endocytic networks (Brass et al. [@CR6]). HIV-1 intracellular endocytic trafficking is linked to viral assembly and budding. The latter occurs within the MVB and in the endoplasmic reticulum and Golgi membranes (Orenstein et al. [@CR39]; Pelchen-Matthews et al. [@CR41]). Although endolysosomal compartments are in BC, specific endocytic pathways and endosome sub-types used for intra- and intercellular viral processing remained unknown (Rustom et al. [@CR45]; Uchil and Mothes [@CR52]) until now.

Herein, we explored intra- and intercellular HIV-1 macrophage endocytic trafficking routes. It is as follows. Intracellular transport begins with receptor binding and internalization into clathrin-coated pits. This is followed by viral recruitment into early sorting endosomes representing large tubular networks directing downstream endocytic sorting (Christoforidis et al. [@CR13]; Maxfield and McGraw [@CR36]). Viral uncoating may occur at this stage, explaining the absence of mature HIV-1 in the BC or within endocytic vesicles (Miyauchi et al. [@CR37]). From the early sorting endosomes, viral constituents may undergo a range of processing routes and may be targeted to the MVB. These represent a subpopulation of late endosomes that serve as intermediate stations for recycling and secretion (de Gassart et al. [@CR15]; Gruenberg and Stenmark [@CR28]). HIV-1 may also undergo maturation here and then following fusion with Rab11 endosomes virus, is recruited to, and then released from the plasma membrane (Maxfield and McGraw [@CR36]; Pelchen-Matthews et al. [@CR41]). Possible back fusion of lysosomes and MVB with Rab11 compartments would explain viral targeting to MVB and "secretory" or non-degrading lysosomes. This is followed by viral trafficking to the plasma membrane where exosome and protein exocytosis occur (Maxfield and McGraw [@CR36]; Pelchen-Matthews et al. [@CR41]). Early endosomes may also fuse with Rab11 and be directed to the perinuclear region and into the endocytic recycling compartment (Maxfield and McGraw [@CR36]). These can then target to the plasma membrane of effecter cells for HIV-1 assembly or transport through bridging conduits to uninfected cells. Such HIV-1 intra- and intercellular sorting pathways are summarized in Fig. [7](#Fig7){ref-type="fig"}. Fig. 7Pathways of macrophage intra- and intercellular HIV-1 trafficking. HIV-1 receptor-mediated entry is regulated by clathrin-coated pits (Miyauchi et al. [@CR37]). Upon inhibition of dynamin by dynasore, viral entry is blocked. Clathrin-coated vesicles containing HIV-1 may undergo Rab5/EEA1-dependant fusion with the early sorting endosome(Bucci et al. [@CR9]; Zerial and McBride [@CR57]). Endosomes can pinch off the vesiculo-tubular network also termed early sorting endosome (Maxfield and McGraw [@CR36]) and undergo the following downstream sorting routes: **a** fuse with the endocytic recycling compartment (ERC; perinuclear region) and then undergo Tfn-like Rab11-mediated recycling to the BC and plasma membrane (Maxfield and McGraw [@CR36]). Disruption of this processes by brefeldin A results in accumulation of HIV-1 constituents in large cytosolic compartments (Wang et al. [@CR54]). **b** undergo sorting to the MVB for ILV biogenesis, virus assembly and budding regulated by ESCRT family (Babst et al. [@CR1]; Garrus et al. [@CR23]; Gill et al. [@CR26]). MVB in turn may undergo fusion with Rab11 endosomes to be transported either to the plasma membrane for exosomal release (Simons and Raposo [@CR49]) or intercellular transfer through the conduits. Disruption of MVB biogenesis by wortmannin results in agregation of HIV-1 constituents in large vaccuoles (Gruenberg and Stenmark [@CR28]). Lysosomes may undergo backfusion with MBV and Rab11 compartments to be targeted at the plasma membrane (secretory non-degrading lysosomes; (Blott and Griffiths [@CR4]; Luzio et al. [@CR34]) or the bridging conduits. In parallel to endocytic entry and intercellular trafficking, virion-plasma membrane fusion may also occur followed by uncoating, reverse trancription, formation of pre-integration complexes (PIC), and RNA expression (Brass et al. [@CR6]). *Thick blue arrows* indicate trafficking routes that target HIV-1 directly to the conduits

What targets viral constituents to a neighboring cell requires further investigation. Previous studies demonstrated the presence of antigen-presenting MHCII-CD4 complexes and HIV-1 proteins in BC formed between macrophages, B cells and T cells in lymph nodes (Brown et al. [@CR8]; Chinnery et al. [@CR12]; Xu et al. [@CR56]). Proteomic and confocal analyses also identified these proteins in the macrophage BC. Since HLA-DR is the most abundant protein in the HIV-1 Env, it is likely that processing of HIV-1 may be guided by CD4-HLA-DR endocytic processing (Callahan et al. [@CR10]; Ott et al. [@CR40]). This could explain similarities in HLA-DR processing routes and trafficking of viral constituents within MVB recycling compartments (Fernandes et al. [@CR22]; Raposo et al. [@CR43]; Romagnoli et al. [@CR44]). These processes may be relevant for viral spread in vivo. HIV-1 may exploit the high mobility and antigen presentation characteristics of macrophages as a "Trojan Horse" for immune escape and dissemination.

Equally important issues remain; such as, can infectious virus be transmitted ell-to-cell from within endocytic compartments and does this mode of viral transfer result in the productive infection? MVB are likely infectious (Pelchen-Matthews et al. [@CR41]). Our works demonstrate that in addition to MVB, which may carry HIV-1, early and recycling endosomes and lysosomes also transmit viral RNA and proteins. Regardless of abundant presence of HIV-1 constituents and RNA within endosomes, we were unable to identify mature HIV-1 within BC and immune isolated endosomes. Mature HIV-1 was frequently observed in the extracellular space. Instead, high-density endocytic compartments were easily identified and those carrying capsid-like structures were rarely observed. Although we performed extensive TEM analysis, we do not exclude the possibility that BC endocytic compartments could also carry mature HIV-1. However, there was a discrepancy between the viral loads and infectivity of endocytic compartments as well as our inabilities to observe mature virus by ultrastructural tests. We posit that a potential alternate route of HIV-1 dissemination and productive infection through the conduits could exist. This would involve sequestration of HIV-1 in endocytic compartments followed by uncoating and content mixing (Miyauchi et al. [@CR37]). These viral cargoes would then be shuttled to uninfected target cells where viral components, although disassembled, could be capable of initiating infection.

If this were the case, then how is viral material unloaded from the endosomes to the cytosol of target cells? Recent studies on the MLV replication cycle have shown that Rab11 endosomes carrying MLV RNA have the ability to fuse with or bud from the cytosol either to release RNA in proximity to the nucleus or transport newly synthesized viral RNA to the plasma membrane (Basyuk et al. [@CR2]). Similar to MLV, our data show that HIV-1 and cellular RNA primarily traffick within and between cells by Rab11 recycling endosomes. This would also explain how viral material gains access to effector cell endosomes and to target cell cytosol via BC. In addition to the relay of viral constituents by direct endosome-endosome fusion (clathrin pits-early endosomes-early endosomes-recycling endosomes or MVB-recycling endosomes), it is likely that budding and fusion of Rab11 with the cytosol allow loading of newly synthesized and original viral constituents into endosomes along with subsequent unloading into uninfected cells via BC-mediated transport. This process may be facilitated by seamless flow of endocytic compartments between BC-connected cells. Indeed, we observed that upon reaching the target cells, endosome transport was not interrupted and these compartments either fused with autochthonous endocytic compartments or preserved their original membranes. Additionally, connected polarized cells were observed to share organelles such as ER and Golgi (our unpublished observations). Formation of a cellular network that precedes and can lead to syncytium formation may allow the connected cells to function as a unicellular organism (Kadiu et al. [@CR31]). Therefore, processes of viral assembly, maturation, release (in the effecter cell) as well as entry, and disassembly (in the target cells) are voided, thus reducing both transfer time and exposure to the host immune system (Martin and Sattentau [@CR35]). Nonetheless, the infectivity of disassembled virus has not been previously reported. Processing of viral constituents into overlapping, yet different sorting routes suggests such a mode of viral transfer may exist and represents a barrier in designing efficient and targeted therapeutic strategies against HIV-1 infection.

Alternatively, HIV-1 may be trafficked from cell to cell within endosomes. We posit that four potential mechanisms may account for intercellular transfer of virus. *First*, MDM become productively infected, and newly synthesized virus gains access to intracellular membranes of neighboring cells where they are assembled and then transported to uninfected cells. This is however not very likely to occur since metabolic tracing of newly synthesized HIV-1 Env and Gag revealed targeting of these proteins to the plasma membrane rather than the conduits (our unpublished observations). *Second*, HIV-1 could be internalized by a polarized macrophage during secondary infection or "superninfection". Internalized virus may be then directly "recycled" to adjacent cells. *Third*, macrophages could "archive" mature HIV-1 progeny in endocytic compartments and upon contact, transfer HIV-1-containing compartments through BC to uninfected cells. *Fourth*, although HIV-1 was distributed primarily with non-degrading compartments, we cannot exclude the possibility that transfer of HIV-1 to the uninfected cell may be driven by apoptosis of the effecter cells. Natural killer cells use conduits as a means for transfer of apoptotic bodies from dying cells (Chauveau et al. [@CR11]). A similar process may occur in macrophages, as a function of their phagocytic and debris clearing activities. Although, low levels of cell death were measured in polarized MDM mixed cultures (our unpublished observations), uninfected MDM were often observed to form contacts with multinucleated giant cells. Therefore it is likely that endocytosed HIV-1 or progeny assembling in intracellular membranes during the initial stages of cell death may exploit transport of apoptotic bodies through the conduits as a means of survival. We posit that transmission of replication competent virus and transfer of viral constituents could occur in tandem. The processes that drive HIV-1 intercellular transfer by direct cell--cell contact nonetheless requires further investigation. Whether or not alternative transfer of viral constituents facilitate the viral life cycle or perhaps incite infection remains an open question.
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BC are distinct from macrophage migratory processes. **A** Images of MDM anchored to the substrate by lamellopodia stained for filamentous actin (F-actin, red) and microtubules (green; scale bars, 10 μm). (JPEG 72 kb)
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High resolution image (TIFF 4068 kb)

###### 

Receptor-mediated HIV-1 sequestration into endosomes and intercellular traffic. **A** MDM in mixed culture are stained against non-neutralizing HIV-1 Env (red) and CD4 FITC-conjugated (green). CD4-HIV-1 Env are identified in large compartments along the BC by confocal microscopy (insets 1 and 2). **B** TEM image of the coronal section of polarized infected cells showing microvesicles but no HIV-1 docked on the plasma membrane (inset 1, arrows). Images also demonstrate presence of lipid droplets and various high-density endosome populations with no visible mature virions floating within compartments or cytosol. **C** TEM images of the transversal section of a conduit and an adjacent MDM. Images show presence of heterogeneous endosome populations within the conduit (inset 1). An HIV-1-like particle is observed in the extracellular space between the BC and the neighboring cell (inset 1, red arrow). **D** Reverse transcriptase activity in HIV-1 infected MDM pre-treated with cytochalasin D (CD), nocodasole (NOC) prior to plating in adherence (BC disruption) and neutralizing anti-Env Ab and protease inhibitor atazanavir (ATV) (did not affect BC integrity) post-adherence. Data shows inhibition of BC formation and HIV-1 proteases suppress significantly productive infection while exposure to neutralizing antibodies has no significant effect on infection (NS, non significant; \*\*P \< 0.001). **E** Presence of anti-Env neutralizing Ab (red)-CD4 (green) complexes in the BC. MDM in mixed culture were exposed to human anti-Env neutralizing Ab for 1 h at 37°C followed by washing, fixation and staining with anti-human secondary Ab Alexa Fluor594 and anti-CD4. Arrows indicate Env-CD4 colocalization within similar compartments similar to those in panel A. **F** Colocalization of internalized anti-Env neutralizing Ab with early endosomes (EEA1, green; scale bars, 10 μm and insets, 5 μm). **G** Clathrin-dependent entry of HIV-1 in human MDM. MDM were treated with dynasore prior and during exposure to DiD-labeled HIV-1 and viral uptake was analyzed by flow cytometry. **H** Presence of HIV-1 (DiD-labeled, blue) and CD4 (FITC-conjugated, green) in clathrin-coated pits (red). (JPEG 166 kb)
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High resolution image (TIFF 67616 kb)
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Enrichment of BC. **A** Schematic representation of isolation of cellular processes using a Boyden chemotaxis apparatus. Cells are seeded onto a filter membrane (3-μm pore), exposed to uninfected MDM-conditioned culture fluids in the lower chamber, to mimic BC formation in mixed cell culture. **B** TEM image of a cellular process migrated through the filter pore. **C, D** Bright field and confocal images (microtubules, green) of macrophage BC after detachment from cell body (scale bars, 5 μm). (JPEG 85 kb)
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High resolution image (TIFF 28461 kb)
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Distribution of fluorescently-labeled HIV-1 with endocytic compartments. **A--C** MDM in mixed culture were seeded in adherence and then exposed to DiD- (red and blue, A and C) or DiO-labeled HIV-1 (green, B). Recycling compartments were labeled by co-incubation with Tfn conjugated to Alexa Fluor594 (B, red). Cells were fixed and stained for EEA1 (green), LAMP1 (blue), HLA-DR (FITC-conjugated, green) and HIV-1 Gag (red). Pearson's colocalization coefficients indicating percent overlap between selected fluorophores are included (mean% ± S.E.M., n = 70; scale bar 10 μm, insets, 5 μm). (JPEG 101 kb)
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High resolution image (TIFF 6912 kb)
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Identification of hybrid endocytic compartments in the BC. **A--C** Distribution of early endosomal and lysosomal markers in recycling endosomes and MVB. MDM in mixed culture were stained for EEA1 (green), LAMP1 (red) CHMP4a (green), Rab11 (blue, red), and nuclei (DAPI, pseudocolored gray). Pearson's colocalization coefficients are included (mean ± S.E.M., n = 70). **D, E** Diminished presence of HIV-1 constituents on the BC with disruption of MVB biogenesis and endocytic recycling. MDM in mixed culture were with wortmannin and brefeldin A. Cells were then stained for Gag (green), CHMP4a (red) and nuclei (blue). Images show aggregation of HIV-1 Gag in large perinuclear vacuoles and their absence from BC (scale bar 10 μm, insets, 5 μm). (JPEG 153 kb)
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High resolution image (TIFF 15236 kb)
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BC-mediated uninterrupted flow of cellular components between connected cells. **A** Continuity of the microtubule network between the connected cells. MDM in mixed culture were allowed to establish BC and stained for α and β tubulin and DAPI to distinguish between spindle-shaped (polarized) multinucleated giant cells (nuclei appear together) and cells connected through BC (nuclei appear at the extremities of the BC). Image shows two MDM connecting through a conduit. At the point of BC-target cell contact note target cell microtubules wrapping around the conduit microtubules (inset boxes 1, 2). **B** Continuity of endocytic traffic between BC connected cells. Uninfected and infected MDM were labeled with DiO (green) and DiD (red) respectively and seeded in mixed culture for 1 h. Time-lapse imaging frames were extracted every 10 s. Images show presence of green (uninfected origin), red (infected), and yellow (mix, fused) endocytic compartments in the conduits and cell body of connected MDM (inset boxes 1 and 2, circles; scale bar 10 μm, insets, 5 μm). (JPEG 193 kb)
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High resolution image (TIFF 11428 kb)

###### 

Association of Myosin II with endocytic compartments present in the conduits. **A--D** MDM in mixed culture were stained for EEA1 (green), CHMP4a (green), LAMP1 (green), Rab11 (green), and myosin II (red). Images show distribution of myosin II with early endosomes, MVB, recycling endosomes and lysosomes in the conduits (arrows; scale bars 10 μm, insets, 5 μm). Pearson's colocalization coefficients indicating overlap of myosin II with endocytic compartments are included in the images (mean% ± S.E.M; n = 70 cells). (JPEG 132 kb)
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High resolution image (TIFF 4041 kb)
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Three-dimensional morphology of macrophage nanotubes. Video shows a tubular cellular process emanating from a single static MDM (DiD-labeled, white) and displaying 3D flagellum-like motion. Images were taken every 5 s over an interval of 7 min. The movie is played at a speed of 15 frames/s (Scale bar, 10 μm). (MOV 300 kb)
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Nanotubes differ from filopodia-like migratory protrusions. Uninfected and HIV-1-infected MDM were stained with DiD (white) and seeded in mixed culture. Video shows a cell in motion utilizing short and thin protrusions. These are morphologically different and less stable than TNTs. Images were taken every 5 s over an interval of 10 min. The movie is played at a speed of 15 frames/s (Scale bar, 10 μm). (MOV 1425 kb)
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Vesicle trafficking is enhanced in HIV-1-infected MDM. Infected MDM (DiD-labeled; pseudocolored white) at 1 h in single adherent culture display increased intra- and intercellular endocytic vesicle trafficking compared to uninfected MDM (see Movie [S2](#MOESM11){ref-type="media"}). Images were taken every 5 s over an interval of 4 min. The movie is played at a speed of 15 frames/s (scale bar, 10 μm). (MOV 3068 kb)

###### 

Vesicle trafficking in uninfected MDM. Uninfected MDM (DiD-labeled, white) at 1 h in single culture display minimal polarization and endocytic trafficking. Images were taken every 5 s. The movie consists of 30 frames and is played at a speed of 15 frames/s (scale bar, 10 μm). (MOV 381 kb)

###### 

Intercellular transport of endosomes through the bridging conduits. Active endosome transfer (∼1 μm•s^−1^) through a conduit connecting uninfected (DiO-labeled; green) and infected (DiD-labeled; red) cells after 1 h in mixed culture. Images were taken every 5 s. The movie consists of 45 frames and is played at a speed of 15 frames/s (Scale bar, 10 μm). (MOV 614 kb)

###### 

Intra- and intercellular trafficking of fluorescently-labeled HIV-1 in MDM. Uninfected MDM were seeded in adherence and then stained with DiO (green). Cells were exposed to DiD-labeled HIV-1 (red). Cells were imaged every 5 s over an interval of 3 min. The movie is played in tandem for each fluorophore at a speed of 15 frames/s (scale bar, 10 μm). (MOV 1789 kb)
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